STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells – Business Wire (press release)
|
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells
Business Wire (press release) VANCOUVER, British Columbia–(BUSINESS WIRE)–STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells. |
Stamford Daily Voice |
Stamford-Based Cell And Gene Therapy Nonprofit Plans New York Gala
Stamford Daily Voice Stamford-based Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, will celebrate its anniversary with a gGala on Wednesday, April 19, 2017, at 6:30 p.m. at The Harvard Club … |
Stamford Daily Voice |
Stamford-Based Cell And Gene Therapy Nonprofit Plans New York Gala
Stamford Daily Voice Stamford-based Alliance for Cancer Gene Therapy (ACGT), the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, will celebrate its anniversary with a gGala on Wednesday, April 19, 2017, at 6:30 p.m. at The Harvard Club … |
UH System Current News |
Promising anti-aging gene therapy developed through innovative partnership
UH System Current News Promising anti-aging results have been shown by a study of the compound Astaxanthin by researchers at the University of Hawaiʻi John A. Burns School of Medicine in partnership with the life sciences company Cardax Inc. The Astaxanthin compound … |
UH System Current News |
Promising anti-aging gene therapy developed through innovative partnership
UH System Current News Promising anti-aging results have been shown by a study of the compound Astaxanthin by researchers at the University of Hawaiʻi John A. Burns School of Medicine in partnership with the life sciences company Cardax Inc. The Astaxanthin compound … |
KSAT San Antonio |
CAR T: New form of immunotherapy
KSAT San Antonio TAMPA, Fla. (Ivanhoe Newswire) – A new form of immunotherapy is being called a milestone in cancer treatment. Could this be the big break patients have been waiting for? Jeffrey Backer didn’t think he’d be taking a swing ever again. |